Search

everythinglearnresearchcommunity

for

Search:↓

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Severe CCCA may be biologically and clinically different from milder forms.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

CCCA may be caused by both hair traction and an immune response.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

DNA analysis can help tailor alopecia treatment.